Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Eliezer M. Van Allen, Joaquim Bellmunt et al.|Nature Genetics|2018Cited by 701
Management of Salivary Gland Malignancy: ASCO GuidelineJ.L. Geiger, Patrick K. Ha, Nofisat Ismaila et al.|Journal of Clinical Oncology|2021Cited by 401
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell CarcinomaJonathan D. Schoenfeld, Robert I. Haddad, Glenn J. Hanna et al.|JAMA Oncology|2020Cited by 350
Frameshift events predict anti–PD-1/L1 response in head and neck cancerGlenn J. Hanna, Robert I. Haddad, Patrick H. Lizotte et al.|JCI Insight|2018Cited by 279
An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 PatientsNicole G. Chau, Christopher A. French, Clement Ma et al.|JNCI Cancer Spectrum|2019Cited by 226